Providence Divests Tegria: A Shift in Health IT Outsourcing

Providence St. Joseph Health has officially divested the Tegria Services Group to private equity firm Altaris Capital Partners. This transition marks the conclusion of a significant chapter in health system-owned IT consulting. Tegria, which has been an integral part of Providence’s operations, will now operate independently under the stewardship of Altaris, a firm managing approximately $9 billion in assets.

The sale effectively detaches Tegria from its non-profit origins and places it in a competitive landscape focused on scaling its MEDITECH and Epic optimization services. This strategic move allows Tegria to position itself as a “pure-play” competitor in the health information technology (HIT) outsourcing arena, distancing itself from the perceptions of being a captive resource exclusive to Providence.

The timing of this transaction is significant. According to a recent survey, 80% of Chief Information Officers (CIOs) reported either maintaining or increasing their spending on professional services. This trend persists even as other budget lines face cuts. The primary reason for this shift is the challenging labor market for Epic and MEDITECH talent. CIOs are increasingly opting to “rent” expertise rather than hire full-time employees, as they navigate a competitive landscape for skilled professionals.

Strategic Implications for Providence and Tegria

The decision to part ways with Tegria aligns with Providence’s broader financial strategy, particularly following the sale of its Acclara division in 2024. By offloading Tegria, Providence aims to enhance its balance sheet while enabling Altaris to leverage Tegria’s recognized strengths. Tegria’s status as a leader in Payer IT and its accolades, including being ranked as Best in KLAS for MEDITECH hosting, position it favorably against larger, more generalized firms such as Deloitte.

This shift raises questions about Tegria’s ability to thrive without the safety net of its parent organization. Previously viewed with skepticism by rival health systems, Tegria now has the opportunity to assert itself in a market ripe for competition. The fragmentation in the HIT outsourcing sector presents both challenges and opportunities as Tegria seeks to establish its own identity apart from Providence.

As health systems continue to grapple with the complexities of IT demands, the outsourcing of specialized services is likely to become increasingly prevalent. Tegria’s transition to an independent entity under Altaris could significantly impact the competitive dynamics within the health IT industry, potentially reshaping how services are delivered and optimized across various health systems.

In an evolving market, Tegria’s future will depend on its ability to adapt and scale effectively, capitalizing on the growing demand for specialized IT solutions. The outcome of this strategic exit will be closely monitored by stakeholders across the health IT landscape as the firm attempts to carve out its niche in a crowded field.